Methylphenidate-mediated reduction in prefrontal hemodynamic responses to working memory task: A functional near-infrared spectroscopy study

Human Psychopharmacology

Volumn 27, Issue 6, 2012, Pages 615-621

  Ramasubbu, Rajamannar ^a   Singh, Harinder ^b   Zhu, Haifeng ^c   Dunn, Jeff F ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

brain function; functional near infrared spectroscopy (fNIRS); humans; methylphenidate; stimulants; working memory

Indexed keywords

DEOXYHEMOGLOBIN; METHYLPHENIDATE; OXYHEMOGLOBIN; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG RESPONSE; FEMALE; FUNCTIONAL NEAR INFRARED SPECTROSCOPY; FUNCTIONAL NEUROIMAGING; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NEAR INFRARED SPECTROSCOPY; NORMAL HUMAN; PILOT STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE DRUG DOSE; TASK PERFORMANCE; WORKING MEMORY;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FUNCTIONAL NEUROIMAGING; HEMODYNAMICS; HEMOGLOBINS; HUMANS; MALE; MEMORY, SHORT-TERM; METHYLPHENIDATE; NEURONS; NOOTROPIC AGENTS; OXYHEMOGLOBINS; PILOT PROJECTS; PREFRONTAL CORTEX; SPECTROSCOPY, NEAR-INFRARED; YOUNG ADULT;

EID: 84868534355     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2258     Document Type: Article

References (37)

1. American Psychiatric Association, A. P. 2000. Diagnostic and Statistical Manual (4th edn Test Revised). American Psychiatric Association: Washington, DC.
2. Arnsten AF,. 2011. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry 69: e89-e99.
3. Association AP,. 2000. Diagnostic and Statistical Manual (4th edn Test Revised). American Psychiatric Association: Washington, DC
4. Challman TD, Lipsky JJ,. 2000. Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75: 711-721.
5. Cui X, Bray S, Bryant DM, Glover GH, Reiss AL,. 2011. A quantitative comparison of NIRS and fMRI across multiple cognitive tasks. Neuroimage 54: 2808-2821.
6. Ehlis AC, Bahne CG, Jacob CP, Herrmann MJ, Fallgatter AJ,. 2008. Reduced lateral prefrontal activation in adult patients with attention-deficit/ hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res 42: 1060-1067.
7. Foote SL, Freedman R, Oliver AP,. 1975. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res 86: 229-242.
8. Gamo NJ, Arnsten AF,. 2011. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behav Neurosci 125: 282-296.
9. Hirai N, Nishino S,. 2011. Recent advances in the treatment of narcolepsy. Curr Treat Options Neurol 13: 437-457.
10. Hoshi Y,. 2003. Functional near-infrared optical imaging: utility and limitations in human brain mapping. Psychophysiology 40: 511-520.
11. Kawaguchi F,. 2001. Clinically available optical topography system. Hitachi review 50: 18-22.
12. Krimer LS, Muly EC, 3rd, Williams GV, Goldman-Rakic PS,. 1998. Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci 1: 286-289.
13. Kuczenski R, Segal DS,. 1997. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68: 2032-2037.
14. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW,. 2000. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20: RC65.
15. Oldfield RC,. 1971. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
16. Owen AM, McMillan KM, Laird AR, Bullmore E,. 2005. N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25: 46-59.
17. Parsons WD NA,. 1978. Effects of smoking on caffeine clearance. Clin Pharmacol Ther 24: 40-45.
18. Pfurtscheller G, Bauernfeind Gwriessnegger SC, Neuper C,. 2010. Focal frontal (de)oxyhemoglobin responses during simple arithmetic. Int J Psychophysiol 76: 186-192.
19. Pu S, Yamada T, Yokoyama K, et al,. 2011. A multi-channel near-infrared spectroscopy study of prefrontal cortex activation during working memory task in major depressive disorder. Neurosci Res 70: 91-97.
20. Ramasubbu R, Goodyear BG,. 2008. Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: a placebo-controlled fMRI study. Neuropsychiatr Dis Treat 4: 1251-1266.
21. Rao SM, Salmeron BJ, Durgerian S, et al,. 2000. Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast. Am J Psychiatry 157: 1697-1699.
22. Richter MM, Zierhut KC, Dresler T, et al,. 2009. Changes in cortical blood oxygenation during arithmetical tasks measured by near-infrared spectroscopy. J Neural Transm 116: 267-273.
23. Rozans M, Dreisbach A, Lertora JJ, Kahn MJ,. 2002. Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol 20: 335-339.
24. Schecklmann M, Schaldecker M, Aucktor S, et al,. 2011. Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD. J Psychiatr Res 45: 1463-1470.
25. Schlosser RG, Nenadic I, Wagner G, Zysset S, Koch K, Sauer H,. 2009. Dopaminergic modulation of brain systems subserving decision making under uncertainty: a study with fMRI and methylphenidate challenge. Synapse 63: 429-442.
26. Schweitzer JB, Lee DO, Hanford RB, et al,. 2004. Effect of methylphenidate on executive functioning in adults with attention-deficit/ hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry 56: 597-606.
27. Suto T, Fukuda M, Ito M, Uehara T, Mikuni M,. 2004. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biol Psychiatry 55: 501-511.
28. Swanson JM, Cantwell D, Lerner M, MCBurnett K, Hanna G,. 1991. Effects of stimulant medication on learning in children with ADHD. J Learn Disabil 24: 219-230, 255.
29. Takon I,. 2011. Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder. Ann Gen Psychiatry 10: 25.
30. Tomasi D, Volkow ND, Wang GJ, et al,. 2011. Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage 54: 3101-3110.
31. Volkow ND, Wang GJ, Fowler JS, et al,. 1997. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154: 50-55.
32. Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ,. 2002. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol 12: 557-566.
33. Volkow ND, Fowler JS, Wang GJ, et al,. 2008. Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One 3: e2017.
34. Wahr JA, Tremper KK, Samra S, Delpy DT,. 1996. Near-infrared spectroscopy: theory and applications. J Cardiothorac Vasc Anesth 10: 406-418.
35. Wargin W, Patrick K, Kilts C, et al,. 1983. Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 226: 382-386.
36. Weber P, Lutschg J, Fahnenstich H,. 2007. Methylphenidate-induced changes in cerebral hemodynamics measured by functional near-infrared spectroscopy. J Child Neurol 22: 812-817.
37. Zhang N, Yacoub E, Zhu XH, Ugurbil K, Chen W,. 2009. Linearity of blood-oxygenation-level dependent signal at microvasculature. Neuroimage 48: 313-318.